Clinical performance comparison of two medium cut‐off dialyzers
Open Access
- 16 August 2022
- journal article
- research article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 27 (2) , 284-292
Abstract
Introduction: Medium‐cut‐off (MCO) dialyzers may beneficially impact outcomes in patients on hemodialysis.Methods: In a randomized, controlled trial in maintenance hemodialysis patients, the new Nipro ELISIO‐17HX MCO dialyzer was compared to the Baxter Theranova 400 filter regarding middle molecule removal. Furthermore, the suitability of two assays for free lambda‐light chain (λFLC) detection (Freelite vs. N‐Latex) was verified.Results: ELISIO‐HX achieved slightly lower reduction ratios for β2‐microglobulin (71.8 ± 6.0 vs. 75.3 ± 5.8%; p = 0.001), myoglobin (54.7 ± 8.6 vs. 64.9 ± 8.7%; p < 0.001), and kappa‐FLC (62.1 ± 8.8 vs. 56.3 ± 7.7%; p = 0.021). λFLC reduction ratios were more conclusive with the Freelite assay and not different between ELISIO‐HX and Theranova (28.4 ± 3.9 vs. 38.7 ± 13.4%; p = 0.069). The albumin loss of Theranova was considerably higher (2.14 ± 0.45 vs. 0.77 ± 0.25 g; p = 0.001) and the Global Removal ScoreLoss alb largely inferior (30.6 ± 7.4 vs. 82.4 ± 29.2%/g; p = 0.006) to ELISIO‐HX.Conclusions: The new ELISIO‐HX expands the choice of dialyzers for MCO hemodialysis.Keywords
Funding Information
- Nipro
This publication has 28 references indexed in Scilit:
- Haemodiafiltration at increased plasma ionic strength for improved protein‐bound toxin removalActa Physiologica, 2016
- Future Avenues to Decrease Uremic Toxin ConcentrationAmerican Journal of Kidney Diseases, 2016
- MCO Membranes: Enhanced Selectivity in High-Flux ClassScientific Reports, 2015
- The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney DiseasePLOS ONE, 2015
- Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patientsJournal Of Nephrology, 2015
- Serum Polyclonal Immunoglobulin Free Light Chain Levels Predict Mortality in People With Chronic Kidney DiseaseMayo Clinic Proceedings, 2014
- N Latex FLC serum free light-chain assays in patients with renal impairmentClinical Chemistry and Laboratory Medicine (CCLM), 2014
- Serum Free Light Chains and the Risk of ESRD and Death in CKDClinical Journal of the American Society of Nephrology, 2011
- Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- Prothrombin, Albumin and Immunoglobulin A form Covalent Complexes with α1‐Microglobulin in Human PlasmaEuropean Journal of Biochemistry, 1997